Add Yahoo as a preferred source to see more of our stories on Google. A woman in Mountain Home, Arkansas, was quick to pull out her camera when she spotted snow beginning to slide off the roof of a ...

Soundsplash Festival staff have shut down “unsubstantiated” rumours claiming mass “needle spiking” at the Raglan music festival. Word-of-mouth rumours began to circulate today about festival attendees ...

SEATTLE — If you're planning on watching fireworks for New Year's Eve, you may be seeing them through a haze. The fog will reform this evening over some locations for fireworks time, lingering again ...

🎯 These are the companies offering potential breakout setups today Ask WarrenAI Heidelberger Druckmaschinen Q2 FY2025/26 slides: EBITDA doubles as cost-cutting takes effect Company News Published ...

There's a needle approaching Earth at the speed of light. A needle? Pfft! That's no big deal, right? Well, unfortunately, it's a very big deal. A needle traveling this fast can cause devastating ...

Shares of SoundThinking slipped after the maker of the ShotSpotter technology cut its full-year revenue outlook due to contract delays. The stock was down 16%, at $7.09, midday Thursday and has fallen ...

Q3 Highlights: SoundHound reported third-quarter revenue of $42.05 million, beating the consensus estimate of $40.49 million. The conversational AI company reported an adjusted loss of three cents per ...

Voice-communications specialist SoundHound AI (NASDAQ:SOUN) — one of the more riskier but exciting enterprises within the artificial intelligence ecosystem — has given investors more reason to cheer.

Published 07/08/2025, 14:46 0 Aspen Aerogels Q2 2025 slides: EBITDA doubles as cost-cutting takes effect ASPN -2.01% Introduction & Market Context Aspen Aerogels (NYSE: ASPN) shares surged 16.81% to ...

The BMW M3 E46 returns in Drifting Challenge Part 10 with full-throttle slides, high-rev sound, and pure M Power control. Watch this iconic coupe tear through corners in a cloud of smoke, showcasing ...

Early adverse symptoms to predict response to treatment among patients in the I-SPY trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...

Complete or culprit-only revascularisation in STEMI: 10-year outcome of DANAMI-3-PRIMULTI Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...